TSE:CHR

Chorus Aviation Inc (CHR.TO)

23.89
-0.20 (0.83%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
223 watching
0
TOP PICK
This is his boring pick. It operates some of the Express features for Air Canada. Fee based fixed type of contract where the jet fuel variations are pass through. Good yield of 6.61%. Well liked on the Street. Estimated P/E is 10.5 (Analysts’ price target is $9.36)
COMMENT
Doesn't know this well. It pays a safe, decent yield. It ran up recently. One question is renewing their Air Canada deal later and renewals make investors jittery.
PAST TOP PICK
(A Top Pick Oct 23/18, Up 13%) Likes their dividend. They extended their CPA agreement with Air Canada to 2035 which gives them a lot of stable free cash flow. They put this cash into buying airplanes and leasing them at attracive rates.
BUY
He owns this name. They just went through the resigning capacity with Air Canada. They now have a long term arrangement with Air Canada. However they sacrificed some of their earnings for this long term arrangement. The dividend payout is safe. He likes this name. Air Canada took and equity interest in Chorus.
BUY
A secure dividend. They recently re-negotiated their deal with Air Canada, extending it from 2025 to 2035, and took slightly lower priceing to achieve that extension. The street liked this deal which has put a floor on this stock. CHR has a division that leases aircraft which will generate cash flow though it carries a little more risk than the AC deal.
COMMENT
A nice uptrend since 2014-7, then troughed last December. In mid-2018 it stayed at levels as the same as today--this could mean shareholders selling around $8 so they breakeven. He's neutral on this.
TOP PICK
It is a pass through operator, running Jazz airlines for Air Canada. AC-T has a habit of cancelling contracts. The risk of this is now none as they have extended their deal out to 2035. The pilot agreements are secured out to then also. They have good return on operations and have a good return on equity. They have a good leasing business. (Analysts’ price target is $9.43)
BUY
The margins were cut by the new agreement with Air Canada. He owns it in his dividend fund.
BUY
Coincided with the upstick at year's end. October to May sees an uptick in cyclicals like this. It has enjoyed lower lows and lower highs, but has risen above its 200-day moving average which is good--it has gapped higher. We're outside seasonal strength but it's starting to look encouraging.
HOLD
They operated the Air Canada connector flights, receiving a block of hours each year. Recently, they have expanded into aircraft leasing, joining forces with Fairfax. He thinks this will become the growth side of the business. The stock price has fallen and he saw that as a good buy opportunity. He likes the dividend yield.
BUY
He had an issue with their agreement with Air Canada being renegotiated but this time it was more beneficial to Chorus. He thinks it will do well.
DON'T BUY
A significant set of revisions resulting in earnings declining by 5% in 2019. Most recent earnings were down 12%. It trades at 8.5 times PE, but is not free cash flow positive. He would look elsewhere. (Analysts’ price target is $9.39)
TOP PICK
With today's big Air Canada deal, investors will completely look upon CHR different. CHR's 7% dividend will be rock-solid safe. He likes this a lot. He sees a $10-12 target. (Analysts’ price target is $9.14)
WAIT
The industrial sector is coming into seasonality at the end of January. This year the risk/reward is pretty good. It should start to move up by the beginning of February. If this one is not doing something then, then there something specific to this stock that has to be worked through.
WATCH
It has pulled back in price more than he expected. Their Air Canada billable hours should have kept their revenues fairly steady and jet fuel prices have been falling. He thinks the market is concerned over next year's negotiations over billable hours. Their leasing business is expected to continue to be strong. He is watching it now and believes the attractive dividend is safe. (Analysts’ price target is $9.25)
Showing 61 to 75 of 227 entries